Treatment-Free Remission After Second-Line Nilotinib Treatment

Ann Intern Med. 2018 Oct 2;169(7):509-510. doi: 10.7326/L18-0430.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
  • Pyrimidines

Substances

  • Pyrimidines
  • nilotinib